Systemic chronic inflammation pathways

"Systemic chronic inflammation pathways" is not a specific molecule or receptor but rather refers to the complex network of cellular and molecular processes that sustain low-grade, persistent immune activation throughout the body over months to years. These processes involve numerous mediators—including pro-inflammatory cytokines like TNFα and interleukins—immune cells such as monocytes/macrophages and lymphocytes, plasma-derived factors including complement proteins and kinins, transcription factors regulating gene expression during immune responses, metabolic regulators from adipose tissue in obesity-associated states, among others. Chronic dysregulation can drive pathogenesis across diverse diseases including autoimmune disorders (e.g., IBD), asthma/allergy via Th2 responses,[1] cancer through tumor-promoting microenvironments,[3] cardiovascular conditions via vascular injury/remodeling,[2] neurodegeneration by sustained glial activation/injury signals,[5] and metabolic syndromes linked with adipose-driven inflammatory signaling.[2] Because "Systemic chronic inflammation pathways" does not refer to a discrete druggable entity but rather an interconnected set of biological mechanisms involving many targets at once—and because it lacks specificity regarding any one protein/gene/receptor/enzyme—it should not be considered a canonical therapeutic target itself. Instead it describes an area where multiple individual targets may be identified for intervention depending on context.[1][3][4] If you need structured information about specific molecules within these pathways—such as Tumor necrosis factor alpha receptor or Interleukin‑6 receptor—please specify which component you are interested in.

Other names

Systemic chronic inflammationChronic inflammation pathwaysInflammatory pathways (systemic, chronic)

Mechanisms for drugs acting on systemic chronic inflammation include: Inhibition of pro-inflammatory cytokine synthesis/release (e.g., TNFα, ILs); Blockade of inflammatory cell recruitment or activation; Modulation of immune cell signaling pathways such as JAK/STAT or NF-kB pathway inhibition.